Virologic outcomes in early antiretroviral treatment: HPTN 052

• المؤلفون الرئيسيون: Eshleman S., Wilson E., Zhang X., Ou S., Piwowar-Manning E., Eron J., McCauley M., Gamble T., Gallant J., Hosseinipour M., Kumarasamy N., Hakim J., Kalonga B., Pilotto J., Grinsztejn B., Godbole S., Chotirosniramit N., Santos B., Shava E., Mills L., Panchia R., Mwelase N., Mayer K., Chen Y., Cohen M., Fogel J.
• التنسيق: دورية
• منشور في: 2017
• الوصول للمادة أونلاين: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85017113091&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/40472

© 2017 Informa UK Limited, trading as Taylor & Francis Group. Introduction: The HIV Prevention Trials Network (HPTN) 052 trial demonstrated that early antiretroviral therapy (ART) prevented 93% of HIV transmission events in serodiscordant couples. Some linked infections were observed shortly a...